Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BMB-101 by Bright Minds Biosciences for Binge Eating Disorder: Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase I for Binge Eating Disorder. According to...
BMB-101 by Bright Minds Biosciences for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy): Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase I for Dravet Syndrome (Severe Myoclonic Epilepsy...
BMB-101 by Bright Minds Biosciences for Opium (Opioid) Addiction: Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase I for Opium (Opioid) Addiction. According to...
BMB-101 by Bright Minds Biosciences for Alzheimer's Disease: Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase I for Alzheimer's Disease. According to GlobalData,...
BMB-101 by Bright Minds Biosciences for Seizures: Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase I for Seizures. According to GlobalData, Phase...